Credit Suisse’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $998K | Buy |
27,455
+440
| +2% | +$16K | ﹤0.01% | 2266 |
|
|
2023
Q4 | $547K | Buy |
27,015
+938
| +4% | +$19K | ﹤0.01% | 2680 |
|
|
2023
Q3 | $463K | Buy |
26,077
+3,635
| +16% | +$64.6K | ﹤0.01% | 2713 |
|
|
2023
Q2 | $406K | Buy |
22,442
+6,889
| +44% | +$124K | ﹤0.01% | 2872 |
|
|
2023
Q1 | $196K | Buy |
15,553
+2,118
| +16% | +$26.6K | ﹤0.01% | 3104 |
|
|
2022
Q4 | $197K | Buy |
13,435
+13,332
| +12,944% | +$195K | ﹤0.01% | 3171 |
|
|
2022
Q3 | $2K | Buy |
103
+90
| +692% | +$1.75K | ﹤0.01% | 3747 |
|
|
2022
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 4284 |
|